TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
164 hedge funds and large institutions have $324M invested in Tvardi Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 70 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
-14
Holders Change %
-7.87%
% of All Funds
2.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
70
Reduced
44
Closed
26
Calls
$1.89M
Puts
$1.01M
Net Calls
+$879K
Net Calls Change
-$2.01M
Top Buyers
| 1 |
ClearBridge Investments
New York
|
+$4.09M |
| 2 |
BlackRock
New York
|
+$2.15M |
| 3 |
LCG
Lisanti Capital Growth
New York
|
+$1.49M |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$1.4M |
| 5 |
Morgan Stanley
New York
|
+$1.32M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$7.11M |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.54M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.5M |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.5M |
| 5 |
Two Sigma Investments
New York
|
-$1.24M |
